IMPROVE-IT













Pretty funny line actually

I wouldn't be so quick about your assessment of the study. I've heard that there was incremental benefit, and it was safe. We'll have to wait and see. We might be ok. Maybe I should say I hope we're ok

Ya yah
 




































Pretty funny line actually

I wouldn't be so quick about your assessment of the study. I've heard that there was incremental benefit, and it was safe. We'll have to wait and see. We might be ok. Maybe I should say I hope we're ok

Ya yah

Of course the study will show what Merck wants it to…After all, this is the company that brought you VIOXX, FOSOMAX, and GARDASIL…very trustworthy data I am sure!!
 
























The results won't show a statistically significant difference either way. If they did, they would have been disclosed by now. My guess is that there is a very small numerical advantage for drug but not close to statistically significant. There may be a subgroup of the population which shows greater benefit. The relevance of this would be hotly debated.